| Literature DB >> 28182718 |
Qing Wang1, Jiachao Guo2, Henglong Hu1, Yuchao Lu1, Jiaqiao Zhang1, Baolong Qin1, Yufeng Wang1, Zongbiao Zhang1, Shaogang Wang1.
Abstract
OBJECT: To compare the safety and efficacy of rigid ureteroscopic lithotripsy (rigid URSL) and percutaneous nephrolithotomy (PCNL) in treating large proximal ureteral stones.Entities:
Mesh:
Year: 2017 PMID: 28182718 PMCID: PMC5300230 DOI: 10.1371/journal.pone.0171478
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flowchart of the literature search and studies selection.
Characteristics and methodological quality of included studies.
| Study | Study | Surgical | Sample | Age | Sex | Stone side | Postoperative | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reference, year | Nation | design | LOE | quality | technique | Type of facility | size | (year) | (M/F) | Stone burden | (left/right) | SWL |
| (M±SD) | ||||||||||||
| Sun et al, 2008 | China | RCT | 2 | - | URSL | Rigid ureteroscope | 47 | 39.6±7.3 | 31/16 | 14.6±1.8 mm | ND | No |
| mini-PCNL | Rigid ureteroscope | 44 | 40.4±8.4 | 30/14 | 14.7±2.0 mm | ND | ||||||
| Basiri et al, 2008 | Iran | RCT | 2 | - | URSL | Semi-rigid ureteroscope | 50 | 39±15 | 33/17 | 17.8±2.4 mm | 26/22 | No |
| PCNL | Rigid nephroscope | 50 | 48±13 | 32/18 | 20.3±3.3 mm | 31/19 | ||||||
| Liu et al, 2013 | China | RCT | 2 | - | URSL | Rigid ureteroscope | 45 | 43.41±10.17 | 25/20 | 148.13±27.52mm3 | 23/22 | Yes |
| mini-PCNL | Rigid ureteroscope | 45 | 46.35±0.31 | 23/22 | 146.85±30.36mm3 | 24/21 | ||||||
| Gu et al, 2013 | China | RCT | 2 | - | URSL | Semi-rigid, flexible ureteroscope | 29 | 44.22± 13.0 | 17/12 | 16.23(15–25)mm | 12/17 | Yes |
| mini-PCNL | Rigid ureteroscope | 30 | 42.5 ± 10.1 | 17/13 | 17.27(15–25)mm | 16/14 | ||||||
| Qi et al, 2014 | China | RCT | 2 | - | URSL | Semi-rigid, flexible ureteroscope | 52 | 42.5±10.3 | 31/21 | 19.8±4.3mm | 30/22 | Yes |
| PCNL | Rigid nephroscope | 52 | 41.1±12.4 | 30/22 | 20.3±3.6mm | 27/25 | ||||||
| Maheshwari et al, | India | CS | 3 | 7/9 | URSL | Rigid ureteroscope | 20 | ND | 14/6 | ND | ND | Yes |
| 1999 | PCNL | Rigid ureteroscope, | 23 | ND | 15/8 | ND | ND | |||||
| Juan et al, 2008 | China | CS | 3 | 8/9 | URSL | Semi-rigid ureteroscope | 31 | 48.9 ± 12.5 | 23/8 | 18.6 ± 6.3mm | 18/13 | No |
| PCNL | Rigid nephroscope, semi-rigid ureteroscope | 22 | 48.2 ± 11.2 | 16/6 | 20.1 ± 5.4mm | 13/9 | ||||||
| Li et al, 2013 | China | CS | 3 | 9/9 | URSL | Semi-rigid, flexible ureteroscope | 91 | 45.35±12.51 | 44/47 | 20.61±4.26 mm | 45/48 | No |
| PCNL | Rigid nephroscope | 83 | 44.12±11.56 | 46/37 | 20.00±4.44mm | 39/44 | ||||||
| Zhu et al, 2014 | China | CS | 3 | 8/9 | URSL | Semi-rigid ureteroscope | 22 | 49.6±7.1 | 14/8 | 1.2±0.8cm | 12/10 | Yes |
| PCNL | Rigid nephroscope | 30 | 51.9±8.4 | 18/12 | 1.4±0.7cm | 17/13 | ||||||
| Bozkurt et al, | Turkey | CS | 3 | 8/9 | URSL | Semi-rigid, flexible ureteroscope | 41 | 42.1 ± 14.9 | 27/18 | 261 ± 47mm2 | ND | No |
| 2015 | PCNL | Rigid nephroscope | 45 | 44.7 ± 16.3 | 22/19 | 314 ± 64mm2 | ND |
RCT: randomized controlled trial CS: cohort study LOE: level of evidence URSL: ureteroscopic lithotripsy PCNL: percutaneous nephrolithotomy SWL: extracorporeal shock wave lithotripsy ND: not demonstrated.
*The quality of the non-randomized controlled trials (nRCTs) was assessed using the Newcastle-Ottawa Scale.
** Totally 91 patients were included in the URSL group, the authors didn’t mention bilateral stones and they might report a wrong ratio of stone side.
# The author might report the gender ratio inversely in two groups.
Fig 2(A) Risk of bias for randomized controlled trials. (B) Funnel plot of the operation time.
Fig 3Forest plots of (A) operation time, (B) hospital stay.
Fig 4Forest plots of (A) The 3rd-day stone-free rate, (B) The 1st-month stone-free rate with and without postoperative auxiliary SWL.
Fig 5Forest plots of conversion, migration and ureteral perforation.
Fig 6Forest plots of fever, transfusion, embolization, hematuria, pain, and ureterostenosis.
Results of sensitivity analysis.
| Sample size | Test for | Test for | ||||||
|---|---|---|---|---|---|---|---|---|
| Items | Studies | URSL/ PCNL | Heterogeneity | overall effect | RR / WMD | Favor | ||
| I2 | P | Z | P | 95% CI | ||||
| Operation time(min) | [ | 220/220 | 99% | <0.001 | 1.02 | 0.31 | -18.08[-52.96,16.80] | |
| Hospital stay(d) | [ | 220/220 | 92% | <0.001 | 8.02 | <0.001 | -3.14 [-3.91, -2.37] | URSL |
| 3-day SFR | [ | 191/190 | 51% | 0.11 | 4.74 | <0.001 | 0.76 [0.68, 0.85] | PCNL |
| 1-month SFR | [ | 139/160 | 0% | 0.93 | 3.55 | 0.0004 | 0.87 [0.81, 0.94] | PCNL |
| Conversion | [ | 128/126 | 0% | 0.83 | 2.09 | 0.04 | 4.92 [1.11, 21.86] | PCNL |
| Migration | [ | 81/82 | 0% | 0.71 | 3.39 | 0.007 | 30.40 [4.23, 218.62] | PCNL |
| Ureteral perforation | [ | 170/170 | 0% | 0.99 | 1.58 | 0.11 | 3.51 [0.74, 16.65] | PCNL |
| Fever | [ | 126/127 | 65% | 0.06 | 1.67 | 0.09 | 0.61 [0.34, 1.09] | |
| Hematuria | [ | 81/82 | 0% | 0.42 | 3.98 | <0.001 | 0.26 [0.14, 0.51] | URSL |
| Operation time(min) | [ | 212/213 | 97% | <0.001 | 2.76 | 0.006 | -29.28 [-50.05, -8.50] | URSL |
| Hospital stay(d) | [ | 192/190 | 97% | <0.001 | 4.67 | <0.001 | -2.77 [-3.93, -1.61] | URSL |
| 3-day SFR | [ | 159/161 | 66% | 0.03 | 4.68 | <0.001 | 0.72 [0.62, 0.82] | PCNL |
| 1-month SFR | [ | 192/190 | 24% | 0.26 | 4.83 | <0.001 | 0.82 [0.75, 0.89] | PCNL |
| Conversion | [ | 120/119 | 0% | 0.77 | 2.37 | 0.02 | 4.81 [1.31, 17.69] | PCNL |
| Migration | [ | 53/52 | 0% | 0.8 | 2.73 | 0.006 | 15.60 [2.18, 111.80] | PCNL |
| Ureteral perforation | [ | 109/111 | 0% | 0.94 | 1.49 | 0.14 | 3.84 [0.65, 22.60] | PCNL |
| Fever | [ | 76/67 | 0% | 0.38 | 1.79 | 0.07 | 0.37 [0.12, 1.10] | |
| Transfusion | [ | 51/45 | 0% | 0.83 | 1.6 | 0.11 | 0.18 [0.02, 1.48] | |
URSL: (rigid) ureteroscopic lithotripsy PCNL: percutaneous nephrolithotomy SFR: stone-free rate.
RR: relative risk WMD: weighted mean difference CI: confidence interval.
* P<0.05 was considered statistically significant
** Originally significant before nRCTs were excluded.
***Originally significant before studies using flexible ureteroscope were excluded.